I think their drug utilization group may be seeing a surge in new clients, as this is going to become a requirement for all drugs soon??? This additional revenue is not included in any analyst estimate........

One question is the reason some company like MCeson may be looking at this co? I think there are some segments that the co's compete, but this company's client base is the reason for such a merger...........

I am in with an ~ 67 but I may add more shares soon at any dip.